로딩 중…
StockDiggingStockDigging

Meta Biomed Co., Ltd.

059210· KOSDAQ
₩3,810-1.93%
2026-06-19

Price Chart

Meta Biomed Co., Ltd.-34.08%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap103.52B KRW
Revenue99.67B KRW
Net Income9.52B KRW
Total Assets189.82B KRW
Net Assets127.95B KRW
Employees296
Value
P/E10.88x
P/B0.81x
P/S1.04x
EV/EBITDA4.19x
FCF Yield-2.58%
Profitability
ROE7.44%
ROA5.01%
Op. Margin20.73%
Revenue Growth-11.84%
Earnings Growth-22.22%
Financial Health
Debt Ratio148.36%
FCF-2.67B KRW
Cash16.93B KRW
Current Ratio1.55x
Net Debt/EBITDA-0.82x
Dividend
Div. Yield2.70%
Div. Growth250.00%
Performance
1Y Return-34.08%
1M Return-4.99%
From 52W High-42.27%
1Y MDD-48.08%
Trading
Volume234,822 shares
Foreign Own.5.56%
Per Share
EPS358 KRW
BPS4,693 KRW

Company Info

CEO 오석송
Employees 296
Founded 1999
HQ 충청북도 청주시, KR

Meta Biomed, established in 1990 and listed on KOSDAQ in 2008, researches, develops, produces, and sells medical devices, including dental materials and suture raw threads. The company has secured a global network with two production and four sales bases, expanding into medical fields by utilizing biocompatible polymer materials. It aims to diversify its medical material business and stabilize its profit structure by developing polymer fillers as a new venture. Meta Biomed was established in 1999 and is headquartered in Cheongju, Chungcheongbuk-do.